MedPath

Bipolar Enbloc Versus Thulium-Yag Enbloc Resection of Bladder Tumors

Not Applicable
Active, not recruiting
Conditions
Bladder Cancer
Interventions
Procedure: Bipolar enbloc resection of bladder tumor
Procedure: Thulium laser enbloc resection of bladder tumor
Registration Number
NCT06119724
Lead Sponsor
Menoufia University
Brief Summary

Prospective controlled study randomized comparing bipolar enbloc versus thulium enbloc for bladder tumours

Detailed Description

Bladder cancer is the ninth most prevalent cancer worldwide and the 2nd most common urologic cancer in the last two decades after cancer prostate .

Most bladder cancers attributed to exposure to environmental and occupational chemicals, the largest of which by far is tobacco smoke. Greater tobacco smoke and occupational exposure in men may help in the explanation of the 4-fold gender difference in bladder cancer incidence .

Approximately 75-85% of patients with bladder cancer present with disease confined to the mucosa or submucosa , which is referred to as nonmuscle invasive bladder cancer (NMIBC).

Transurethral resection of bladder tumor (TURBT) is still considered the gold standard treatment for primary nonmuscle invasive bladder cancer.

There are many drawbacks for conventional TURBT procedure such as such as the deficiency of the bladder detrusor muscle In the specimen

, the obturator jerk, thermal damage to surrounding tissues, and the technique of( incise and scatter). These drawbacks may lead to difficulty in performing an accurate pathological evaluation of fragment tissue and increase the risk of recurrence.

Laser therapy for bladder cancer was first reported in Germany in the 1970s and was approved to clinical use in the USA in 1984.

Modern laser technology has led to new alternatives to conventional transurethral resection of bladder tumor (TURBT) due to its efficacy and good control of bleeding. With the introduction of en-bloc resection of urinary bladder tumors, Laser come back into focus. The two most commonly used lasers at present are thulium and holmium Laser.

In 2018 PA Geavlete, declared that the enbloc bipolar resection of bladder tumors using mushroom loop provide the advantages of superior surgical safety, decreased perioperative morbidity and faster postoperative recovery, when compared to the standard monopolar TURBT but showed no superiority in oncological outcome.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Bipolar enbloc resection of bladder tumorsBipolar enbloc resection of bladder tumorPatients who have odd number will be in the first group which will be enrolled in bipolar enbloc group
Thulium enbloc resection of bladder tumorsThulium laser enbloc resection of bladder tumorpatients who have even number will be in the second group which will be Thulium-Yag laser enbloc group
Primary Outcome Measures
NameTimeMethod
Blood lossImmediate postoperative

Assessed by comparing between Hemoglobin level pre and post operative

Duration of cancer free survival post enbloc resection1year

Duration of Cancer free survival post resection measured by weeks.

Staging of bladder cancer post enbloc resection1year

Clinical staging using bimanual examination under anesthesia.

Presence of residual tumors post resection3-6 months

Assessed by visualization of any residual mass during second look cystoscopy

Enbloc technique effectiveness in obtaining muscle in the speciment3 months

Assessed by presence of muscles in histopathological specimen.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Menoufia university hospital

🇪🇬

Shibīn Al Kawm, Menoufia, Egypt

© Copyright 2025. All Rights Reserved by MedPath